Compression Only CPR Versus Standard CPR in Out-Of-Hospital Cardiac Arrest - A Randomized Survival Study
Launched by KAROLINSKA INSTITUTET · Jun 7, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two types of CPR (cardiopulmonary resuscitation) techniques to see which one works better in helping people who have a cardiac arrest outside of a hospital. Specifically, the trial is comparing "Compression Only CPR" (CO-CPR), which focuses solely on chest compressions, to "Standard CPR" (S-CPR), which includes both chest compressions and rescue breaths. The goal is to find out if CO-CPR is as effective or even better than S-CPR when the person giving help has received CPR training.
To participate in this trial, you need to be someone who has witnessed a cardiac arrest (meaning you saw or heard it happen) and has been trained in CPR. People who are 18 years old or younger, or those who have not been trained in CPR, cannot join this study. If you take part, you will be randomly assigned to use either CO-CPR or S-CPR when helping someone in need. This research is important because it could help increase the chances of survival for people experiencing cardiac arrest and improve how bystanders respond during emergencies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Unconsciousness with no, abnormal or agonal breathing (suspected OHCA)
- • The suspected OHCA is witnessed (seen or heard)
- • Any Bystander at the scene has previous training in CPR
- Exclusion Criteria:
- • Age 18 or younger
- • Collapse is not witnessed
- • Bystander has never been taught CPR. (These bystanders should be instructed to administer CO-CPR in accordance to guidelines)
- • Asphyxia, i.e. drowning, strangulation, hanging
- • Intoxication or drug overdose
- • Pregnancy
- • Trauma
- Post randomisation exclusion Criteria from data analysis:
- • Previous decision that CPR should not be initiated i.e. terminal illness or palliative care
- • No Cardiac arrest, other condition (Cases where EMS did not start CPR)
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Bergamo, , Italy
Patients applied
Trial Officials
Jacob Hollenberg, MD, PhD
Principal Investigator
Karolinska Institutet, Department of Medicine Solna
Giuseppe Ristagno, MD, PhD
Study Chair
University of Milan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials